Clinical Trial Update: Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury [Phase 2]

View source ↗

Summary

Phase 2 efficacy and safety study of magnesium isoglycyrrhizinate injection for acute drug-induced liver injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-induced Liver Injury

Drugs mentioned

• Magnesium isoglycyrrhizinate injection (magnesium isoglycyrrhizinate)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Drug-Induced Liver Injury | Phase 2 | Status: COMPLETED